ARTICLE | Clinical News

HIV Immunotherapeutic data

August 15, 1994 7:00 AM UTC

The San Diego company reported on four patients with CD4 counts >500 enrolled in a Phase I trial of its ex vivo gene therapy for HIV infection.

The patients had fibroblasts removed and transduced with a non-replicating mouse retroviral vector carrying genes encoding the env and rev proteins of HIV. ...